2021
DOI: 10.3390/bios11070206
|View full text |Cite
|
Sign up to set email alerts
|

Dengue Detection: Advances in Diagnostic Tools from Conventional Technology to Point of Care

Abstract: The dengue virus (DENV) is a vector-borne flavivirus that infects around 390 million individuals each year with 2.5 billion being in danger. Having access to testing is paramount in preventing future infections and receiving adequate treatment. Currently, there are numerous conventional methods for DENV testing, such as NS1 based antigen testing, IgM/IgG antibody testing, and Polymerase Chain Reaction (PCR). In addition, novel methods are emerging that can cut both cost and time. Such methods can be effective … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
43
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 53 publications
(47 citation statements)
references
References 204 publications
(274 reference statements)
0
43
0
Order By: Relevance
“…Microfluidics is a multipurpose technology that combines several technologies. This also has advantages such as reduced reagent use, little material handling, and a quick test time (Kabir et al, 2021).…”
Section: Detection Of Dengue Virusmentioning
confidence: 99%
“…Microfluidics is a multipurpose technology that combines several technologies. This also has advantages such as reduced reagent use, little material handling, and a quick test time (Kabir et al, 2021).…”
Section: Detection Of Dengue Virusmentioning
confidence: 99%
“…The dengue virus can be diagnosed by viral RNA detection in reverse transcriptase-polymerase chain reaction (RT-PCR) or non-structural protein 1 (NS1) via enzyme-linked immunosorbent assay (ELISA) and lateral flow immunoassay (LFIA). The NS1 antigen is a non-structural glycoprotein, which could reach up to 50 μg/mL in the serum of certain dengue virus-infected patients. As a result, its presence is often used to diagnose the disease .…”
Section: Introductionmentioning
confidence: 99%
“…However, antibody responses could be detected only at 3-5 days after the onset of fever, rendering early detection implausible [6,7]. The detection of DENV non-structural protein 1 (NS1) by ELISA or rapid diagnostic test (RDT) has also been widely used, but sensitivity (up to 70% false negative rate) varied among DENV serotypes and manufacturers [8][9][10][11][12], as reviewed by A. Kabir et al [13]. Reverse transcription loopmediated isothermal amplification (RT-LAMP) was also developed as a diagnostic tool for use in areas with limited resources [14,15].…”
Section: Introductionmentioning
confidence: 99%